Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 21, 2014; 20(43): 16037-16052
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16037
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16037
Figure 5 Sensitivity, specificity, and 95%CI for the four model for end-stage liver disease-based prognostic models used to predict mortality with the best predictive cut offs at 3 mo[67].
- Citation: Philips CA, Sarin SK. Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation. World J Gastroenterol 2014; 20(43): 16037-16052
- URL: https://www.wjgnet.com/1007-9327/full/v20/i43/16037.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i43.16037